Skip to main content

Advertisement

SpringerLink
Log in

Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mallbris L, Ljungberg A, Hedblad MA et al (2003) Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol 48(2):290–293

    Article  PubMed  Google Scholar 

  2. Kovach BT, Calamia KT, Walsh JS, Ginsburg WW (2004) Treatment of multicentric reticulohistiocytosis with etanercept. Arch Dermatol 140(8):919–921

    Article  PubMed  Google Scholar 

  3. Sacher C, Rubbert A, Konig C et al (2002) Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept. J Am Acad Dermatol 46(1):113–115

    Article  PubMed  Google Scholar 

  4. Tan MH, Gordon M, Lebwohl O et al (2001) Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 137(7):930–933

    CAS  PubMed  Google Scholar 

  5. Swale VJ, Saha M, Kapur N et al (2005) Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab. Clin Exp Dermatol 30(2):134–136

    Article  CAS  PubMed  Google Scholar 

  6. Singh M, Andrew SM, Lear JT (2004) Infliximab as a treatment for recalcitrant pyoderma gangrenosum. Clin Exp Dermatol 29(2):196–197

    Article  CAS  PubMed  Google Scholar 

  7. Regueiro M, Valentine J, Plevy S et al (2003) Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 98(8):1821–1826

    Article  CAS  PubMed  Google Scholar 

  8. Zaccagna A, Bertone A, Puiatti P et al (2003) Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn’s disease. Eur J Dermatol 13(3):258–260

    PubMed  Google Scholar 

  9. Ljung T, Staun M, Grove O et al (2002) Pyoderma gangrenosum associated with Crohn disease: effect of TNF-(alpha) blockade with infliximab. Scand J Gastroenterol 37(9):1108–1110

    Article  CAS  PubMed  Google Scholar 

  10. Brooklyn TN, Dunnill MG, Shetty A et al (2006) Infliximab for treatment of pyoderma gangrenosum: a randomized, double blind placebo controlled trial. Gut 55(4):505–509

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fonder MA, Cummins DL, Ehst BD et al (2006) Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 5:e8

    PubMed  PubMed Central  Google Scholar 

  12. Shalaby MR, Palladino MA, Hirabayashi SE et al (1987) Receptor-binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol 41(3):196–204

    Article  CAS  PubMed  Google Scholar 

  13. Skov L, Baadsgaard O (2000) Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 25(1):57–61

    Article  CAS  PubMed  Google Scholar 

  14. Kloppenburg M, Breedveld FC, Terwiel JP et al (1994) Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 37(5):629–636

    Article  CAS  PubMed  Google Scholar 

  15. Ritchlin C, Tausk F (2006) A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents. Ann Rheum Dis 65(12):1541–1544

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    K. Vandevyvere, F. P. Luyten, P. Verschueren, R. Lories & R. Westhovens

  2. Division of Dermatology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    S. Segaert

Authors
  1. K. Vandevyvere
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. P. Luyten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Verschueren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Lories
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Segaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Westhovens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Westhovens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vandevyvere, K., Luyten, F.P., Verschueren, P. et al. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis. Clin Rheumatol 26, 2205–2206 (2007). https://doi.org/10.1007/s10067-007-0733-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0733-8

Keywords

Search

Navigation